For patients with hepatic impairment, no evidence-based dosing guideline exists
Miquilena-Colina ME, Lima-Cabello E, Sanchez-Campos S, Garcia-Mediavilla MV, Fernandez-Bermejo M, Lozano-Rodriguez T, Vargas-Castrillon J, Buque X, Ochoa B, Aspichueta P, Gonzalez-Gallego J, Garcia-Monzon C (2011) Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C
These smart agents minimize off-target toxicity while maximizing reactive oxygen species production at disease sites, thereby enhancing therapeutic efficacy and safety [74]
The enzymes will also often affect the liver, and can back up through the bile duct, causing inflammation there also
So that when Cd stress is enhanced, plants intensify sulfur metabolism to mitigate the toxic effects of heavy metals [43, 44]